Dr. Sergio Jaramillo, MD

Dr. Jaramillo practices at Ambulatory Surgery Center at Berthelsen Main Campus in Houston, Texas.

Dr. Jaramillo's NPI, 1659767127, was assigned on April 11, 2015. Dr. Jaramillo graduated from Baylor College Of Medicine in 2015. Dr. Jaramillo holds Texas license BP20058072.

Dr. Jaramillo's primary practice is Ambulatory Surgery Center at Berthelsen Main Campus, at 2727 W Holcombe Blvd, Houston, TX 77025. The practice phone is (713) 442-3300.

Dr. Jaramillo's primary practice is Ambulatory Surgery Center at Berthelsen Main Campus in Houston, Texas. The medical group on file is Kelsey-Seybold Clinic. Dmand AI also links Dr. Jaramillo to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jaramillo practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Jaramillo's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Jaramillo is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Jaramillo's licenses on file in 2 states: Texas and Louisiana.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and lymphoma radiation among the conditions Dr. Jaramillo treats.

CMS data shows 1,984 Medicare services from Dr. Jaramillo across 15 procedure codes in 2024, for 234 Medicare patients. Medicare paid $111,192 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 234 Medicare patients who saw Dr. Jaramillo in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have cancer, and 75% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jaramillo's median patient age at 59, with 44% women.

In 2024, Dr. Jaramillo wrote 255 Medicare Part D claims for 76 patients. 94% of them were for generic drugs. CMS names the drug for 169 of them, across 4 drugs with 11 or more claims each, at $1,896 in total drug cost. In 2023, CMS named 110 claims across 4 drugs.

Dr. Jaramillo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Jaramillo, published from 2016 to 2022. 2016 was the busiest year, with 2. Dr. Jaramillo has published most often in Clin Transl Radiat Oncol. Dr. Jaramillo's most frequent co-authors are David Randall Grosshans, MD, Anita Mahajan, MD and Susan Lynne McGovern, MD.

CMS Open Payments shows 31 general payments to Dr. Jaramillo from 17 drug and device companies from 2018 to 2025. Travel and lodging make up the largest share, 51% of the total. Profound Medical Corp. paid the most, $2,867.

Dmand AI lists 5 awards for Dr. Jaramillo, most recently PTCOG 60 Travel Fellow in 2022.

Dr. Jaramillo graduated from Baylor College Of Medicine in 2015.

Dr. Jaramillo is in network with 13 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.